Cubed Biotech is a Montréal-based Canadian psychedelic biotechnology firm federally licensed from Health Canada to develop, manufacture, and commercialize psychedelic medicine in order to unnerve the current treatments of mental illness & addiction. We cultivate, extract, and purify natural entheogens (i.e., psilocybin from mushrooms, mescaline from cacti, and ayahuasca’s DMT and monoamine oxidase inhibitors) with synthetic options. Our 19,000 square feet Montreal facility is the preeminent psychedelic factory in the world as told to us by a Nasdaq CEO. Cubed’s drug development is focused on reverse engineering natural medicines with safe historical usage to produce finished drug products for Cubed and pharmaceutical companies.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Montreal, Toronto, New York, Ca
- Industry
- Biotechnology
- HQ
- Montreal, Toronto, New York
Cubed Biotech Questions
Cubed Biotech's LinkedIn profile is https://ca.linkedin.com/company/cubed-biotech
Cubed Biotech has
8 employees.
View email and phone details for 8
employees at Cubed Biotech.
Cubed Biotech's industry is
Biotechnology
Cubed Biotech's top competitors are
Force One Capital,
Cult Yogourt,
Spindle Biotech Inc.,
Iconthin Biotech,
Garrington Capital,
Afl,
Force One Marketing,
Pharmala Biotech Inc. (Mdma.cse),
Js Cpa Strategic Solutions Professional Corporation,
Albedo Biotech.
Cubed Biotech's categories are Biotechnology
Cubed Biotech's founding year is 2020
